Skip to main content
  • MEETINGS
  • JOBS/RFPs
  • FUNDING
 

You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialize correctly.

Home

Bert Lubin, M.D. biography

Board Members

Chair
Jonathan Thomas, Ph.D., J.D.

Vice-chairs
Duane Roth
Art Torres, J.D.

Patient Advocate
Marcy Feit, RN, MSN
Leeza Gibbons
Sherry Lansing
Francisco J. Prieto, M.D.
Robert A. Quint, M.D., FSCAI
Joan Samuelson, J.D.
David Serrano Sewell, J.D.
Jeff Sheehy
Jonathan Shestack
Oswald Steward, Ph.D.

Executive officer, Commercial Life Science Entity
Michael Goldberg
Stephen Juelsgaard, D.V.M., J.D.

Executive officer, California Research Institute
Bert Lubin, M.D.
Michael A. Friedman, M.D.
Shlomo Melmed, M.D.
Kristina Vuori, M.D., Ph.D.

Executive officer, California University
Robert Birgeneau, Ph.D
Philip A. Pizzo, M.D.
Carmen A. Puliafito, M.D., M.B.A.

Executive officer, UC with a medical school
David Brenner, M.D.
Susan V. Bryant, Ph.D.
Sam Hawgood, M.B., B.S.
Claire Pomeroy, M.D., M.B.A.
Eugene Washington, M.D., M.Sc.

Members

     

Bertram Lubin

Bertram Lubin, M.D.

An executive officer of a California Research Institute
Appointed by the Controller

Dr. Lubin is currently serving as the President and Chief Executive Officer of Children's Hospital & Research Center Oakland.

Throughout his career in medicine, Dr. Lubin has directed his energies to fostering biomedical research and has been involved in a number of clinical and basic research projects. His primary research interest has been in sickle cell disease. He developed a Sickle Cell Screening, Counseling, and Education Program at Children’s Hospital Oakland (CHO), and subsequently with a UCSF colleague, started the Northern California Comprehensive Sickle Cell Center, a program that is in its twenty-third year of NIH funding. Lubin was a member of the NIH Executive Committee that initiated the Cooperative Study of Sickle Cell Disease, a program that supported clinical research in sickle cell disease for over fifteen years. He is an editor of the NIH-published monograph "Current Treatment for Sickle Cell Anemia."

In addition to his interest in clinical hematology, Lubin directed a NIH-funded basic research program to study membrane phospholipid organization in human red blood cells. His group discovered that alterations in membrane phospholipids occurred when cells containing sickle hemoglobin were deoxygenated and that these changes could contribute to clinical events that occur in sickle cell anemia.

Recently, Lubin began the CHO Related Donor Cord Blood Program. The program is offered to families across the United States who currently have a child with a blood disorder such as sickle cell anemia, thalassemia, aplastic anemia, or leukemia, and are expecting another child. Following the birth of a healthy child, blood remaining in the placenta (cord blood) is harvested. Because cord blood is enriched with bone marrow cells, it is cyropreserved and can later be used for
transplantation. A number of lives have been saved following transplantation with cord blood units collected in this program.

Dr. Lubin has many general interests in pediatric research and research education. These range from asthma, obesity, diabetes, and nutrition to studies of the neonate. He is particularly interested in how environmental factors interact with genetics to cause disease. He is involved in the UC Berkeley Pediatric Environmental Health Center, providing core laboratory services to investigate the effects of pesticide exposure during pregnancy on the health of children. He is the director of the Pediatric Clinical Research Center at Children’s Hospital Oakland, the director of an Institutional Post-Doctoral Training Program, and the director of a Short Term Minority Training Program for Undergraduate Students, all of which are NIH-supported. He participates in a number of projects with NIH staff, has served on many NIH peer-review committees, has been a reviewer for many biomedical scientific journals, and is on a number of biomedical advisory committees.
 

 

Newsletter Sign-Up

Receive press releases, funding announcements or other news from CIRM.

>> Click here to sign up

Follow Us

Facebook Updates
YouTube Videos
Twitter
Flickr Images
LinkedIn
Research Blog
RSS Feeds

 

« May 2012 »
MonTueWedThuFriSatSun
123456
78910111213
14151617181920
21222324252627
28293031
Bookmark and Share
  • Contact Us
  • Privacy Policy
  • Accessibility
  • Site Map
© 2009 California Institute For Regenerative Medicine